tradingkey.logo
tradingkey.logo

Neogen Corp

NEOG
7.130USD
-0.010-0.14%
終値 12/26, 16:00ET15分遅れの株価
1.55B時価総額
損失額直近12ヶ月PER

Neogen Corp

7.130
-0.010-0.14%

詳細情報 Neogen Corp 企業名

Neogen Corporation and subsidiaries are engaged in developing, manufacturing and marketing a diverse line of products and services dedicated to food and animal safety. The Company has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. Its segments include Food Safety and Animal Safety. The Food Safety segment is primarily engaged in the development, production and marketing of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens and levels of general sanitation. The Animal Safety segment is primarily engaged in the development, production and marketing of products dedicated to animal safety, including a complete line of consumable products marketed to veterinarians and animal health product distributors. This segment also provides genomic identification and related interpretive bioinformatic services.

Neogen Corpの企業情報

企業コードNEOG
会社名Neogen Corp
上場日Aug 23, 1989
最高経営責任者「CEO」Nassif (Mikhael)
従業員数2974
証券種類Ordinary Share
決算期末Aug 23
本社所在地620 Lesher Pl
都市LANSING
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号48912
電話番号15173729200
ウェブサイトhttps://www.neogen.com/
企業コードNEOG
上場日Aug 23, 1989
最高経営責任者「CEO」Nassif (Mikhael)

Neogen Corpの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
116.12K
+28.34%
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Operating Officer
Chief Operating Officer
90.39K
+11.56%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
57.24K
+29.59%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
45.53K
+107.76%
Dr. Catherine E. Woteki, Ph.D.
Dr. Catherine E. Woteki, Ph.D.
Independent Director
Independent Director
36.86K
+178.32%
Dr. Ronald D. Green, Ph.D.
Dr. Ronald D. Green, Ph.D.
Independent Director
Independent Director
36.40K
+184.78%
Ms. Andrea F. Wainer
Ms. Andrea F. Wainer
Independent Director
Independent Director
25.86K
+324.61%
Mr. Thierry Bernard
Mr. Thierry Bernard
Independent Director
Independent Director
25.39K
+351.76%
Mr. Avi Pelossof
Mr. Avi Pelossof
Director
Director
19.39K
--
Mr. Bryan Riggsbee
Mr. Bryan Riggsbee
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. James C. (Jim) Borel
Mr. James C. (Jim) Borel
Independent Chairman of the Board
Independent Chairman of the Board
116.12K
+28.34%
Mr. David Hartman Naemura
Mr. David Hartman Naemura
Chief Operating Officer
Chief Operating Officer
90.39K
+11.56%
Dr. Amy M. Rocklin, Ph.D.
Dr. Amy M. Rocklin, Ph.D.
Chief Legal & Compliance Officer
Chief Legal & Compliance Officer
57.24K
+29.59%
Ms. Aashima Gupta
Ms. Aashima Gupta
Independent Director
Independent Director
45.53K
+107.76%
Dr. Catherine E. Woteki, Ph.D.
Dr. Catherine E. Woteki, Ph.D.
Independent Director
Independent Director
36.86K
+178.32%
Dr. Ronald D. Green, Ph.D.
Dr. Ronald D. Green, Ph.D.
Independent Director
Independent Director
36.40K
+184.78%

収益内訳

通貨: USD更新時刻: Mon, Oct 6
通貨: USD更新時刻: Mon, Oct 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Culture Media & Other
325.92M
36.43%
Bacterial & General Sanitation
164.78M
18.42%
Rodenticides, Insecticides & Disinfectants
135.03M
15.09%
Genomics Services
89.25M
9.98%
Natural Toxins, Allergens & Drug Residues
77.06M
8.61%
他の
102.62M
11.47%
地域別USD
会社名
収益
比率
International
448.73M
50.16%
Domestic
445.94M
49.84%
事業別
地域別
事業別USD
会社名
収益
比率
Culture Media & Other
325.92M
36.43%
Bacterial & General Sanitation
164.78M
18.42%
Rodenticides, Insecticides & Disinfectants
135.03M
15.09%
Genomics Services
89.25M
9.98%
Natural Toxins, Allergens & Drug Residues
77.06M
8.61%
他の
102.62M
11.47%

株主

更新時刻: Tue, Nov 25
更新時刻: Tue, Nov 25
株主統計
種類
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
13.46%
The Vanguard Group, Inc.
11.01%
Clarkston Capital Partners, LLC
5.38%
Gates Capital Management, Inc.
5.02%
Norges Bank Investment Management (NBIM)
4.18%
他の
60.95%
株主統計
株主統計
比率
BlackRock Institutional Trust Company, N.A.
13.46%
The Vanguard Group, Inc.
11.01%
Clarkston Capital Partners, LLC
5.38%
Gates Capital Management, Inc.
5.02%
Norges Bank Investment Management (NBIM)
4.18%
他の
60.95%
種類
株主統計
比率
Investment Advisor
47.86%
Investment Advisor/Hedge Fund
31.94%
Hedge Fund
12.39%
Research Firm
8.49%
Bank and Trust
4.90%
Sovereign Wealth Fund
4.25%
Pension Fund
2.05%
Individual Investor
0.89%
Insurance Company
0.04%

機関投資家保有株

更新時刻: Wed, Oct 1
更新時刻: Wed, Oct 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q3
733
254.38M
117.06%
-53.44M
2025Q2
720
240.23M
110.60%
-42.75M
2025Q1
753
280.62M
129.30%
-9.42M
2024Q4
764
265.86M
122.55%
-15.84M
2024Q3
778
258.29M
119.19%
-21.39M
2024Q2
791
255.45M
117.89%
-8.15M
2024Q1
783
241.86M
111.66%
-5.94M
2023Q4
783
234.38M
108.27%
-1.28M
2023Q3
770
225.33M
104.20%
-18.20M
2023Q2
761
232.20M
107.41%
-2.78M
詳細を見る

株主動向

会社名
保有株式数
比率
変動額
変動率
日付
BlackRock Institutional Trust Company, N.A.
27.55M
12.68%
-1.06M
-3.71%
Jun 30, 2025
The Vanguard Group, Inc.
23.53M
10.83%
+27.21K
+0.12%
Jun 30, 2025
Clarkston Capital Partners, LLC
14.01M
6.45%
+7.73M
+123.16%
Jun 30, 2025
Gates Capital Management, Inc.
12.79M
5.89%
+3.64M
+39.72%
Jun 30, 2025
Norges Bank Investment Management (NBIM)
9.08M
4.18%
-5.73M
-38.70%
Jun 30, 2025
State Street Investment Management (US)
8.59M
3.95%
-18.09K
-0.21%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
9.13M
4.2%
+697.10K
+8.26%
Jun 30, 2025
Mackenzie Investments
7.81M
3.6%
+54.59K
+0.70%
Jun 30, 2025
Baron Capital Management, Inc.
6.85M
3.15%
-692.37K
-9.18%
Jun 30, 2025
詳細を見る

関連ETF

更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
State Street SPDR S&P Health Care Equipment ETF
1.97%
Invesco S&P SmallCap Health Care ETF
0.82%
Invesco NASDAQ Future Gen 200 ETF
0.58%
VanEck Agribusiness ETF
0.32%
Federated Hermes MDT Small Cap Core ETF
0.27%
Inspire Small/Mid Cap ESG ETF
0.22%
Amplify Etho Climate Leadership U.S. ETF
0.21%
Invesco S&P SmallCap 600 Pure Value ETF
0.2%
State Street SPDR S&P 600 Small Cap Value ETF
0.18%
iShares S&P Small-Cap 600 Value ETF
0.18%
詳細を見る
State Street SPDR S&P Health Care Equipment ETF
比率1.97%
Invesco S&P SmallCap Health Care ETF
比率0.82%
Invesco NASDAQ Future Gen 200 ETF
比率0.58%
VanEck Agribusiness ETF
比率0.32%
Federated Hermes MDT Small Cap Core ETF
比率0.27%
Inspire Small/Mid Cap ESG ETF
比率0.22%
Amplify Etho Climate Leadership U.S. ETF
比率0.21%
Invesco S&P SmallCap 600 Pure Value ETF
比率0.2%
State Street SPDR S&P 600 Small Cap Value ETF
比率0.18%
iShares S&P Small-Cap 600 Value ETF
比率0.18%

配当金

過去5年間の配当金総支払額は 0.00 米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし

株式分割

日付
種類
比率
May 12, 2021
Split
1→2
日付
種類
比率
May 12, 2021
Split
1→2

よくある質問

Neogen Corpの上位5名の株主は誰ですか?

Neogen Corpの上位5名の株主は以下のとおりです。
BlackRock Institutional Trust Company, N.A.は27.55M株を保有しており、これは全体の12.68%に相当します。
The Vanguard Group, Inc.は23.53M株を保有しており、これは全体の10.83%に相当します。
Clarkston Capital Partners, LLCは14.01M株を保有しており、これは全体の6.45%に相当します。
Gates Capital Management, Inc.は12.79M株を保有しており、これは全体の5.89%に相当します。
Norges Bank Investment Management (NBIM)は9.08M株を保有しており、これは全体の4.18%に相当します。

Neogen Corpの株主タイプ上位3種は何ですか?

Neogen Corpの株主タイプ上位3種は、
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Clarkston Capital Partners, LLC

Neogen Corp(NEOG)の株式を保有している機関の数はいくつですか?

2025Q3時点で、Neogen Corpの株式を保有している機関は733社あり、保有株式の総市場価値は約254.38Mで、全体の117.06%を占めています。2025Q2と比較して、機関の持ち株は6.47%増加しています。

Neogen Corpの最大の収益源は何ですか?

FY2025において、Culture Media & Other部門がNeogen Corpにとって最大の収益を生み出しており、その金額は325.92Mで、全収益の36.43%を占めています。
KeyAI